GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Cyclically Adjusted PS Ratio

Rohto Pharmaceutical Co (TSE:4527) Cyclically Adjusted PS Ratio : 3.43 (As of Jun. 07, 2024)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-06-07), Rohto Pharmaceutical Co's current share price is 円3002.00. Rohto Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円874.02. Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 3.43.

The historical rank and industry rank for Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:4527' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.94   Med: 2.52   Max: 4.86
Current: 3.16

During the past years, Rohto Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 4.86. The lowest was 1.94. And the median was 2.52.

TSE:4527's Cyclically Adjusted PS Ratio is ranked worse than
86.08% of 1386 companies
in the Consumer Packaged Goods industry
Industry Median: 0.8 vs TSE:4527: 3.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Rohto Pharmaceutical Co's adjusted revenue per share data for the three months ended in Dec. 2023 was 円320.370. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円874.02 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Rohto Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.18 2.09 2.47 3.39 -

Rohto Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.39 3.88 4.74 3.25 -

Competitive Comparison of Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Rohto Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=3002.00/874.02
=3.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Rohto Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=320.37/106.8000*106.8000
=320.370

Current CPI (Dec. 2023) = 106.8000.

Rohto Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 177.514 95.700 198.103
201406 133.462 98.000 145.446
201409 162.684 98.500 176.392
201412 175.900 97.900 191.891
201503 194.660 97.900 212.356
201506 155.396 98.400 168.662
201509 183.187 98.500 198.623
201512 187.933 98.100 204.600
201603 202.644 97.900 221.066
201606 144.314 98.100 157.112
201609 167.770 98.000 182.835
201612 175.091 98.400 190.038
201703 188.955 98.100 205.712
201706 156.921 98.500 170.144
201709 185.958 98.800 201.015
201712 199.148 99.400 213.974
201803 208.838 99.200 224.838
201806 177.619 99.200 191.227
201809 203.589 99.900 217.651
201812 207.480 99.700 222.255
201903 214.118 99.700 229.366
201906 182.921 99.800 195.751
201909 212.125 100.100 226.323
201912 208.253 100.500 221.308
202003 220.060 100.300 234.321
202006 169.451 99.900 181.155
202009 193.601 99.900 206.973
202012 203.738 99.300 219.126
202103 224.550 99.900 240.059
202106 184.978 99.500 198.549
202109 212.844 100.100 227.090
202112 231.624 100.100 247.127
202203 243.144 101.100 256.852
202206 228.424 101.800 239.643
202209 253.732 103.100 262.838
202212 288.240 104.100 295.716
202303 272.764 104.400 279.034
202306 267.363 105.200 271.429
202309 291.535 106.200 293.182
202312 320.370 106.800 320.370

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Rohto Pharmaceutical Co  (TSE:4527) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Rohto Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines